Naproxen- and ibuprofen-containing regimens are more effective, and also cost-effective, than tramadol and celecoxib for patients with knee osteoarthritis who also have cardiovascular disease and diabetes, a new model of benefits and costs has concluded. Writing in Osteoarthritis and Cartilage, a team based at the Brigham and Women’s Hospital at Harvard Medical School, analysed the ...
Naproxen and ibuprofen favoured in co-morbid knee OA
By Tony James
29 Oct 2015